Skip to content

Screening of serologic markers in the process of gastric mucosal carcinogenesis and its application in clinical practice

Screening of serologic markers in the process of gastric mucosal carcinogenesis and its application in clinical practice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092843
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

Chronic non-atrophic gastritis:none
Intestinal metaplasia:none
Gastric polyp:none
Gastric ulcer:none
Low-grade intraepithelial neoplasia:none
High grade intraepithelial neoplasia:none

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Hospital outpatient gastroenterology clinic attendees 2)Age >= 18 years old, gender is not limited 3)Patients who intend to undergo gastroscopy and biopsy 4)Cases with pathologic diagnosis of findings of chronic non-atrophic gastritis/chronic atrophic gastritis/intestinal epithelial hyperplasia/gastric polyps/gastric ulcers/low-grade intraepithelial neoplasia/high-grade intraepithelial neoplasia 5)Those who agree to participate in the project, agree to the serum being used for screening of serologic markers, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Combined with other malignant tumors, serious cardiovascular and cerebrovascular diseases or abnormal organ functions 2)History of previous gastric surgery 3)Taking antibiotics, bismuth, H2 receptor blockers or proton pump inhibitors within the last 4 weeks. 4)Combined judgment of poor compliance and inability to accurately provide the information needed for the study, e.g., low literacy, significant psychiatric or psychological disorders.

Design outcomes

Primary

MeasureTime frame
Enzyme linked immunosorbent assay;ELISA;

Countries

China

Contacts

Public ContactChangjiang Hu

The Second Affiliated Hospital of Army Medical University

hcj_888@126.com+86 23 6875 5604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026